Endogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPARγ-dependent autocrine mechanism
Open Access
- 1 September 2010
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 299 (3), H690-H698
- https://doi.org/10.1152/ajpheart.01032.2009
Abstract
In experimental animal and cell culture models, activation of peroxisome proliferator-activated receptor (PPAR) γ in heart has been shown to have beneficial effects on cardiac function and cardiomyocyte physiology. The goal of this study was to identify the signaling pathway by which PPARγ activation protects cardiomyocytes from the deleterious effects of hypertrophic stimuli. In primary cardiomyocyte cultures, we found that genetic or pharmacological activation of PPARγ protected cells from cardiac hypertrophy induced by α-adrenergic stimulation. Examination of gene expression in these cells revealed a surprising increase in the expression of adiponectin in cardiomyocytes and secretion of the high-molecular-weight form of the hormone into media. Using RNAi to block PPARγ-induced adiponectin production or adiponectin receptor gene expression, we found that the PPARγ-mediated anti-hypertrophic effect required cardiomyocyte-produced adiponectin, as well as an intact adiponectin signaling pathway. Furthermore, mice expressing constitutive-active PPARγ and cardiomyocyte specific adiponectin expression were protected from high-fat diet-induced cardiac hypertrophy and remodeling. These findings demonstrate that functional adiponectin hormone can be produced from the heart and raise the possibility that beneficial effects of PPARγ activation in heart could be due in part to local production of adiponectin that acts on cardiomyocytes in an autocrine manner.Keywords
This publication has 37 references indexed in Scilit:
- Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor γJournal of Molecular and Cellular Cardiology, 2007
- Activation of PPARγ enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulationJournal of Lipid Research, 2005
- Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARγ agonistsAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Peroxisome Proliferator-Activated Receptor Agonists Modulate Heart Function in Transgenic Mice with Lipotoxic CardiomyopathyJournal of Pharmacology and Experimental Therapeutics, 2005
- Adiponectin-mediated modulation of hypertrophic signals in the heartNature Medicine, 2004
- Long-term effects of the PPARγ activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive ratsCanadian Journal of Physiology and Pharmacology, 2004
- Thiazolidinedione Use, Fluid Retention, and Congestive Heart FailureCell Metabolism, 2003
- Muscle-specific Pparg deletion causes insulin resistanceNature Medicine, 2003
- Bradykinin-stimulated protein synthesis by myocytes is dependent on the MAP kinase pathway and p70S6KAmerican Journal of Physiology-Heart and Circulatory Physiology, 1999